Scenic Biotech

About:

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.

Website: http://www.scenicbiotech.com/

Top Investors: Oxford Science Enterprises, Inkef, BioGeneration Ventures, Vesalius Biocapital Partners, Netherlands Enterprise Agency

Description:

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors as a new class of drug targets.The company's immunotherapy technologies tackle diseases on the genetic level and focuses on disease suppressing genes., it uses genomics to develop innovative therapies for patients affected by severe diseases.

Total Funding Amount:

37.6M EUR

Headquarters Location:

Amsterdam, Noord-Holland, The Netherlands

Founded Date:

2017-01-01

Contact Email:

info(AT)scenicbiotech.com

Founders:

Sebastian Nijman, Thijn Brummelkamp

Number of Employees:

11-50

Last Funding Date:

2022-03-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai